TIGIT and B-cell chronic lymphocytic leukemia: If overactivated, the TIGIT pathway leads to an abnormal intracellular transduction of suppressive stimuli in T and NK cells, thus facilitating neoplastic cell survival in CD155+ neoplasms, such as CLL and RS [85,87,88].